ESMA LIBRARY

The ESMA Library contains all ESMA documents. Please use the search and filter options to find specific documents.
25
DOCUMENTS

REFINE YOUR SEARCH

Sections

Type of document

Your filters
Technical Advice X Technical Standards X Statement X Warnings and publications for investors X Corporate Finance X COVID-19 X
Reset all filters

Pages

Date Ref. Title Section Type Download Info Summary Related Documents Translated versions
06/01/2021 ESMA32-339-149 Public Statement Targeted Longer-Term Refinancing Operations III Corporate Finance Statement PDF
115.66 KB
12/10/2020 ESMA22-105-1248 Steven Maijoor Opening Statement for ECON Hearing 12 October 2020 Board of Supervisors, Brexit, Corporate Information, COVID-19, Joint Committee, Speeches Statement PDF
134.36 KB
21/07/2020 ESMA32-61-417 Public Statement on supervisory action on accounting for COVID-19 lease modifications COVID-19, IFRS Supervisory Convergence Statement PDF
120.44 KB
09/07/2020 ESMA34-39-109 Public statement on external support within the meaning of Article 35 of the MMF Regulation COVID-19, Fund Management Statement PDF
118.34 KB
11/06/2020 ESMA70-156-3070 Statement_Access ETDs COVID-19, MiFID - Secondary Markets, Post Trading Statement PDF
112.54 KB
20/05/2020 ESMA32-63-972 Implications of the COVID-19 outbreak on the half-yearly financial reports Corporate Disclosure, COVID-19 Statement PDF
111.97 KB
14/05/2020 ESMA50-158-2232 ESMA supports ESRB actions to address COVID-related systemic vulnerabilities COVID-19, Fund Management Statement PDF
81.33 KB
06/05/2020 ESMA35-43-2391 Reminder of firms’ MiFID II conduct of business obligations in the context of increasing retail investor activity COVID-19, MiFID - Investor Protection Statement PDF
118.75 KB
04/05/2020 ESMA71-99-1324 Statement on bilateral margin RTS amendments in response to Covid-19 COVID-19, Joint Committee, Post Trading, Press Releases Statement PDF
101.16 KB
09/04/2020 ESMA70-155-9817 ESMA postpones the publication dates of the annual transparency calculations for non-equity instruments and for the quarterly systematic internaliser data for non-equity instruments other than bonds COVID-19, MiFID - Secondary Markets, MiFID II: Transparency Calculations and DVC Statement PDF
94.58 KB
09/04/2020 ESMA80-187-546 Actions to mitigate the impact of COVID-19 on the EU financial markets regarding the timeliness of fulfilling external audit requirements for interest rate benchmarks under the Benchmarks Regulation Benchmarks, COVID-19 Statement PDF
89.31 KB
09/04/2020 ESMA34-45-896 Actions to mitigate the impact of COVID-19 on the deadlines for the publication of periodic reports by fund managers COVID-19, Fund Management Statement PDF
113.03 KB
31/03/2020 ESMA35-36-1919 Clarification of issues related to the publication of reports by execution venues and firms as required under RTS 27 and 28 COVID-19, MiFID - Investor Protection Statement PDF
89.84 KB
27/03/2020 ESMA31-67-742 Public statement on publication deadlines under the Transparency Directive COVID-19, Transparency Statement PDF
88.72 KB
26/03/2020 ESMA80-191-995 COVID-19 Public Statement COVID-19, Securities Financing Transactions Statement PDF
113.93 KB
25/03/2020 ESMA32-63-951 Accounting implications of the COVID-19 outbreak on the calculation of expected credit losses in accordance with IFRS 9 Corporate Disclosure, COVID-19 Statement PDF
135.91 KB
20/03/2020 ESMA70-1556-2485 Public Statement Tick Sizes COVID-19, MiFID - Secondary Markets Statement PDF
79.25 KB
20/03/2020 ESMA35-43-2348 ESMA Statement on COVID-19 telephone recording COVID-19, MiFID - Investor Protection Statement PDF
114.12 KB
11/03/2020 ESMA71-99-1290 ESMA Statement on Markets and COVID-19 Board of Supervisors, COVID-19 Statement PDF
87.99 KB
30/05/2018 ESMA71-99-991 Statement of the EBA and ESMA on the treatment of retail holdings of debt financial instruments subject to the Bank Recovery and Resolution Directive MiFID - Investor Protection, Warnings and publications for investors Statement PDF
926.71 KB

Pages